Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

White Meets Blue - Enzymicals AG and the Institute of Marine Biotechnologye.V. start to cooperate

14.06.2011
The Enzymicals AG, an emerging company in the field of industrial (white) biotechnology, and the Institute of Marine Biotechnology e.V. (IMaB), an association in the area of marine (blue) biotechnology, have signed a comprehensive agreement to cooperate in the future.The two institutions both located in Greifswald, Germany, combine thereby their competencies in the commercialization of alternative expression systems and functional genome analysisfor the production of fine chemicals.

The signed contract includes the joint use of innovative technologies for the identification and production of novel enzymes from aquatic sources,amongst others. “Dormant potentials of marine habitats for biotransformations can be deciphered and brought into market by the focused application of proteomics-based biotechnology”, says Prof. Dr. Thomas Schweder of the IMaB. ”Together with Enzymicals AG, we can offer our expertise in the field of de novo genome sequencing and gene annotation to a wide audience as a service.”

Thewhole value chain can be covered jointly by merchandising of new biocatalysts from aquatic systems and the application-oriented process development by Enzymicals AG.

The two institutionscomplement each other in their strategic alignment perfectly by the construction of expression systems and production strains for applications in fine chemistry.

“Thus, our customers will gain access to exquisite biocatalysts for applications in the chemical and pharmaceutical industry”, adds Dr. Ulf Menyes, CEO of Enzymicals AG, who foresees a strengthening of core competencies by the partnership.

Both new and existing customers will gain a long-term competitive advantage in tailored product and process development based on innovative biocatalysts from the cooperation of both institutions.

About Enzymicals AG:
The Enzymicals AG, Greifswald, was founded as a start-up company in August 2009, initialized by the workgroup of Prof. UweBornscheuer, Institute of Biochemistry at the University of Greifswald. The company specializes in enzymatic reactions for the production of fine and specialty chemicals and the manufacture and sale of biocatalysts.

The interdisciplinary team of biochemists, biologists, synthetic and process chemists is led by Dr. Ulf Menyes (chemist) as chief executive officer (CEO) and Dr. Rainer Wardenga (biologist) as head of research and production (CSO). The Enzymicals AG has establishedcollaborations with leading companies in the chemical industry and established the technical requirements for the production of enzymes and for the biotechnological synthesis of specialty and fine chemicals on kg-scalewithin a short period of time. Enzymicals is member of BioCon Valley MV e.V.

About the Institute of Marine Biotechnologye.V.:
The Institute of Marine Biotechnology e.V. (IMaB) was founded in 1996. The main concern of the institute is to promote and develop research in the field of marine biotechnology. This is done in close cooperation with the Ernst-Moritz-ArndtUniversity of Greifswald. Research interests of the IMaB include the functional genome and proteome analysis of marine microorganisms, the discovery, enrichment and characterization of bioactive compounds from marine organisms and the development of new bacterial expression systems.

A particular focus is on the field of functional genomics of marine microorganisms. The increasing number of sequenced genomes of marine bacteria and the extensive data on marine metagenomes allow a comprehensive insight into the previously unknown metabolic activities of marine organisms. The functional genome analysis is substantially supported by the analysis of the physiological proteome. One of the most modern and best equipped proteome centers in Germany was established at the University of Greifswald in recent years. These technologies are used by the IMaB to determine relevant, new gene functions and to make them accessible for biotechnological applications. The Institute is member of BioCon Valley MV e.V.

Contact:
Enzymicals AG
Dr. Ulf Menyes, CEO
Walther-Rathenau-Str. 49a
17489 Greifswald, Germany
Tel.: +49-3834-515 470
Fax.: +49-3834-515 473
E-Mail: ulf.menyes@enzymicals.com
Institutfür Marine Biotechnologiee.V.
Prof. Dr. Thomas Schweder
Walther-Rathenau-Str. 49A
D-17489 Greifswald
Tel.: +49(0)3834 864212
Fax +49(0)3834 864238
E-Mail: schweder@uni-greifswald.de

Dr. Heinrich Cuypers | idw
Further information:
http://www.enzymicals.com
http://www.marine-biotechnologie.de
http://www.bcv.org

More articles from Life Sciences:

nachricht Multi-institutional collaboration uncovers how molecular machines assemble
02.12.2016 | Salk Institute

nachricht Fertilized egg cells trigger and monitor loss of sperm’s epigenetic memory
02.12.2016 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>